Simplex Trading
MYGN icon

Simplex Trading’s Myriad Genetics MYGN Stock Holding History

Simplex Trading’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.05K Sell
900
-11,400
-93% -$59.4K ﹤0.01% 8017
2025
Q4 		$75.6K Sell
12,300
-700
-5% -$5.08K ﹤0.01% 5269
2025
Q3 		$93K Buy
13,000
+11,900
+1,082% +$70.7K ﹤0.01% 5834
2025
Q2 		$5K Buy
1,100
+300
+38% +$1.77K ﹤0.01% 7752
2025
Q1 		$7K Hold
800
– – ﹤0.01% 7347
2024
Q4 		$10K Sell
800
-4,300
-84% -$79.3K ﹤0.01% 7204
2024
Q3 		$139K Sell
5,100
-700
-12% -$18.9K ﹤0.01% 4895
2024
Q2 		$141K Buy
5,800
+1,800
+45% +$39.5K ﹤0.01% 5002
2024
Q1 		$85K Buy
4,000
+2,100
+111% +$45.1K ﹤0.01% 5754
2023
Q4 		$36K Sell
1,900
-5,500
-74% -$95.1K ﹤0.01% 6398
2023
Q3 		$118K Buy
7,400
+800
+12% +$15.2K ﹤0.01% 4925
2023
Q2 		$152K Buy
6,600
+3,600
+120% +$78.6K ﹤0.01% 4611
2023
Q1 		$69K Buy
+3,000
New +$60.9K ﹤0.01% 5566
2022
Q4 		– Sell
-5,600
Closed -$106K – 9960
2022
Q3 		$106K Sell
5,600
-3,200
-36% -$73.4K ﹤0.01% 5440
2022
Q2 		$159K Buy
8,800
+5,300
+151% +$110K ﹤0.01% 4916
2022
Q1 		$88K Buy
3,500
+600
+21% +$15.4K ﹤0.01% 6329
2021
Q4 		$80K Buy
2,900
+200
+7% +$5.79K ﹤0.01% 6581
2021
Q3 		$84K Hold
2,700
– – ﹤0.01% 6866
2021
Q2 		$82K Buy
2,700
+2,645
+4,809% +$76.4K ﹤0.01% 7017
2021
Q1 		$167K Sell
55
-42
-43% -$1.19K ﹤0.01% 5027
2020
Q4 		$191K Sell
97
-373
-79% -$6.02K ﹤0.01% 4667
2020
Q3 		$612K Buy
470
+31
+7% +$392 ﹤0.01% 2768
2020
Q2 		$497K Buy
439
+399
+998% +$5.67K ﹤0.01% 2918
2020
Q1 		$57K Buy
40
+14
+54% +$296 ﹤0.01% 4996
2019
Q4 		$70K Sell
26
-61
-70% -$1.68K ﹤0.01% 4881
2019
Q3 		$249K Sell
87
-343
-80% -$9.99K ﹤0.01% 3345
2019
Q2 		$1.19M Buy
430
+281
+189% +$7.94K ﹤0.01% 1750
2019
Q1 		$494K Buy
149
+90
+153% +$2.74K ﹤0.01% 2677
2018
Q4 		$171K Buy
59
+19
+48% +$684 ﹤0.01% 3316
2018
Q3 		$184K Sell
40
-11
-22% -$489 ﹤0.01% 3730
2018
Q2 		$190K Sell
51
-110
-68% -$3.71K ﹤0.01% 3543
2018
Q1 		$9K Sell
161
-43
-21% -$1.46K ﹤0.01% 4139
2017
Q4 		$75K Buy
204
+84
+70% +$2.83K ﹤0.01% 2054
2017
Q3 		$138K Sell
120
-26
-18% -$742 0.01% 1463
2017
Q2 		$45K Buy
146
+125
+595% +$2.65K ﹤0.01% 2487
2017
Q1 		$3K Buy
+21
New +$372 ﹤0.01% 5032
2016
Q4 		– Sell
-77
Closed -$1K – 6286
2016
Q3 		$1K Buy
77
+24
+45% +$609 ﹤0.01% 5381
2016
Q2 		$2K Sell
53
-59
-53% -$2.05K ﹤0.01% 4966
2016
Q1 		$10K Sell
112
-67
-37% -$2.52K ﹤0.01% 3461
2015
Q4 		$18K Sell
179
-3
-2% -$127 ﹤0.01% 2788
2015
Q3 		$212K Sell
182
-92
-34% -$3.27K 0.02% 872
2015
Q2 		$59K Buy
274
+208
+315% +$7.07K ﹤0.01% 1572
2015
Q1 		$32K Sell
66
-102
-61% -$3.65K ﹤0.01% 1909
2014
Q4 		$10K Buy
+168
New +$5.96K ﹤0.01% 2589

Other funds holding MYGN

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Simplex Trading's MYGN Position: Q3 2025 in Review

Simplex Trading sold out of Myriad Genetics (MYGN) in Q3 2025, closing a stake of 14,791 shares — an estimated $87.8K sold.

Simplex Trading first reported a position in MYGN in Q2 2016 and held it in 26 quarters. The position peaked at $1.14M in Q2 2017. 221 funds tracked by Wall St. Rank hold MYGN as of Q3 2025.

  • Simplex Trading reported no remaining Myriad Genetics position as of Q3 2025 after selling out during the quarter.
  • Simplex Trading sold 14,791 Myriad Genetics shares in Q3 2025, an estimated $87.8K.
  • Simplex Trading first reported a position in Myriad Genetics in Q2 2016 and held it in 26 quarters.
  • Simplex Trading's Myriad Genetics position peaked at $1.14M in Q2 2017.
  • 221 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2025.

Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.